To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Not Applicable

Completed

• Conditions: Non Small Cell Lung Cancer
• Interventions: Procedure: Testing for mutation status

• Registration Number: NCT01185314
• Lead Sponsor: AstraZeneca

Brief Summary

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

Detailed Description

A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.

Study Timeline

• Study First Submitted: 2010-08-16
• Study First Submitted QC: 2010-08-18
• Study First Posted: 2010-08-19
• Study Start: 2010-09
• Primary Completion: 2011-07
• Study Completion: 2011-07
• Status Verified: 2011-08
• Last Update Submitted: 2011-08-05
• Last Update Posted: 2011-08-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1270

Inclusion Criteria

• Histological or cytologically confirmed advanced Non small cell lung cancer of adeno histology NSCLC treatment naive Availability of cancer tissue or cytology sample

Exclusion Criteria

• Involvement in the planning and/or conduct of the study Previous enrollment in the present study

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Testing for mutation status	EGFR mutation testing

Primary Outcome Measures

Name	Time	Method
EGFR mutation status of Asian patients with advanced NSCLC	Samples will be tested after informed consent. Mutation results will be available within 1-3 weeks.

Trial Locations

Locations (1)

Research Site; 🇻🇳 Ho Chi Minh City, Vietnam